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Relationship between the Time of Sustained
Ethyl Acrylate Forestomach Hyperplasia and
Carcinogenicity
by B. 1. Ghanayem,1 1. M. Sanchez,' R. R. Maronpot,1
M. R. Elwell,1 and H. B. Matthews1
Chronic administration ofethyl acrylate (EA) by gavage at 100 or 200 mg/kg/day resulted in a
significant dose-dependent increase in the incidence offorestomach (FS) squamous cell papiflo-
mas and carcinomas in both sexes ofF344 rats and B6C3F, mice. Subsequent work in this labo-
ratory was designed to investigate the relationship between EA-induced FS hyperplasia and
carcinogenicity. Current studies have focused on determining the time required for sustained
FS hyperplasia to produce neoplastic transformation. Results of these studies demonstrated
that gavage administration ofEA to male F344 rats at 200 mg/kg/day for 6 or 12 months caused a
sustained increase in FS epithelial hyperplasia for as long as exposure to EA continued.
However, FS hyperplasia regressed, and no neoplasms developed when animals receiving EA
for 6 months were allowed to recover until they were sacrificed at 24 months ofage. In contrast,
rats treated for 12 months and allowed 9 months recovery developed FS squamous cell carcino-
mas (3/13) and papillomas (1/13) for a combined incidence of4/13. No gross lesions were detected
in the liver ofany ofthe rats treated with EA or corn oil vehicle, confirming the tissue specifici-
ty in the relationship between EA-induced FS hyperplasia and carcinogenesis. In conclusion,
the present work has demonstrated that FS hyperplasia is selectively sustained at the site of
EA-induced carcinogenicity for as long as EA is administered and has also demonstrated a tem-
poral relationship between FS mucosal hyperplasia and the development ofFS neoplasia by EA.
It is speculated that whereas a temporal relationship probably exists between FS hyperplasia
and tumor development for many chemicals known to increase cell proliferation, this relation-
ship may vary significantly from one chemical to another and with the target tissue and may be
influenced by the mutagenicity ofchemicals.
Introduction
Ethyl acrylate (EA), the ethyl ester ofacrylic acid, is
produced in large volumes for the manufacture ofpoly-
mers and copolymers that are used to make latex
paint, textiles, paper coatings, dirt release agents, and
specialty plastics such as dental and medical devices.
Acute oral gavage administration of EA to rats caused
severe mucosal and submucosal edema accompanied by
inflammatory infiltration (1-3). In prechronic studies,
EA caused severe forestomach (FS) epithelial hyper-
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plasia and hyperkeratosis (4,5). A recent stop-study in
which 100 or 200 mg EA/kg was administered daily, 5
days/week, for 3 months showed that EA-treated rats
exhibited severe epithelial hyperplasia of the FS.
Forestomachs of EA-treated rats that were allowed a
19-month recovery showed further decline in the inci-
dence and severity of mucosal cell hyperplasia. No
treatment-related lesions were observed at any other
site (5).
Chronic gavage administration of EA resulted in a
significant dose-dependent increase in the incidence of
squamous cell papillomas and carcinomas of the FS in
both sexes ofF344 rats and B6C3Fj mice (6). No treat-
ment-related neoplastic lesions were detected at any
other sites. EA was negative in most mutagenicity
assays with and without metabolic activation, as indi-
cated by testing in several Salmonella typhimurium
strains and in Drosophila (7). However, EA was posi-
tive in one micronucleus mutagenicity study in mice
(8), a findingthat was later disputed by Ashby et al. (9).GHANAYEMETAL.
Chemically-induced cell proliferation is thought to
play a role in the development and progression of
chemically induced neoplasia (4,10-13). Work in this
laboratory has addressed the role of cell proliferation
in EA-induced FS carcinogenesis. In particular, cur-
rent studies have focused on determining the time
required for sustained hyperplasia induced by EA to
lead to neoplastic transformation in the rat FS and the
tissue specificity ofEA-induced cell proliferation.
Methods
Chemicals. Ethyl acrylate [99%, inhibited with 15-20
ppm of hydroquinone monomethyl ether (HQMME)]
was purchased from Aldrich Chemical Company (Mil-
waukee, WI). Corn oil (Mazola brand) was obtained
from Best Foods, CPC International Inc. (Englewood
Cliffs, NJ).
Animals and Treatments. Male F344 rats were
obtained from Charles River Breeding Laboratories
(Raleigh, NC). Rats were housed in polycarbonate
cages and fed NIH 31 diet and water ad libitum in
facilities with a relative humidity of 50 ± 10%, tem-
perature of21-220C, and a 12-hr dark-light cycle. Rats
were housed under these conditions for a minimum of2
weeks before treatment. All animals were approx-
imately 3 months old at the start of treatments. Rats
were assigned numbers that were entered into a
computer and were divided into four groups using a
locally developed computer program that uses body
weight as the basis for randomization. All animal
husbandry and experimental operations were conducted
under NIH guidelines.
Effect ofEAAdministration for 3, 6, or 12 Months
and Recoveries. Two hundred milligrams ofEA/kg in
corn oil (5 mL/kg) was administered to rats daily, 5
days/week, for 6 or 12 months. Control rats received 5
mL corn oil/kg/day, 5 days/week, for 12 months. Five
rats from each treatment group were sacrificed using
CO2 euthanasia at 24 hr after the last dose. The
remaining rats in each treatment group were killed at
24 months of age.
At the time of sacrifice, animals were euthanized
under C02, and organs and tissues were examined for
gross lesions. Tissues were taken and preserved in
10% aqueous buffered neutral formalin. Stomachs
were removed free of other tissues, opened across the
lesser curvature, pinned to a piece of cardboard, and
rinsed before examination. Stomachs were sliced along
the long axis and immediately immersed in 10% aque-
ous buffered neutral formalin. Formalin-fixed stom-
achs were sliced into 3-4 sections, which extended per-
pendicularly from thejunction ofthe FS and glandular
stomach and covered the full length ofthe FS, embed-
ded in paraffin, and stained with hematoxylin/eosin
(H&E). Microscopic evaluation ofcoded slides was per-
formed without priorknowledge oftreatment.
Results
Data presented in this report demonstrated that EA
administration to male F344 rats resulted in the devel-
opment of FS hyperplasia, which was sustained for as
long as EA administration continued. FS hyperplasia
induced by continued administration of EA for 6
months was largely reversible after cessation ofdosing
(Table 1). No treatment-related neoplastic lesions
were observed in the FS of rats exposed to EA for 6
months and sacrificed at 24 months of age (Table 1).
After 12 months of EA administration, forestomachs
of all treated rats showed evidence of hyperplastic
lesions, but there was no evidence of gross or microscop-
ic tumors. However, when animals receiving EA for 12
months were sacrificed after 9 months ofrecovery, gross
examination showed papillomas/carcinomas arising from
the FS mucosa of some chemical-treated animals.
Microscopic diagnosis in H&E-stained sections further
confirmed the development of FS tumors in these EA-
treated rats (Table 1). The incidence ofFS squamous cell
carcinomas and papillomas in EA-treated rats was 3/13
and 1/13, respectively, (combined incidence of4/13).
No significant increase in the incidence of hyperpla-
sia or neoplasia was seen in the FS ofrats treated with
the corn oil vehicle for 12 months and sacrificed at 24
months of age. Further, no neoplastic lesions were
grossly observed in the liver or any other organ ofrats
(except the FS) treated with EA or corn oil vehici e.
Discussion
In a recent stop-study in which 100 or 200 mg EA/kg
was administered daily, 5 days/week, for 3 months,
rats exhibited epithelial hyperplasia of the FS as long
as exposure to EA continued (5). Histopathologic eval-
Table 1. Incidence ofneoplastic and non-neoplastic lesions in the forestomach ofmale F344 rats treated
with ethyl acrylate (EA) for 6 or 12 months foilowed by recovery to 24 months ofage.
Treatment
Forestomach 12 Months CO + 9 6 Months EA + 15 12 Months EA + 9
Lesions 12 Months CO 6 Months EA 12 Months EAa Months recoveryb Months recovery Months recovery
Mucosal hyperplasia 0/5 5/5 5/5 0/16 0/18 8/13
Squamous cell
Papillomas and 0/5 0/5 0/5 0/16 0/18 4/13
Carcinomas
aEthyl acrylate was dissolved in corn oil (CO) and administered by gavage at 200 mg/kg/day, 5 days/weekfor 12 months. Dose volume=5 mL/kg.
bRatstreated with 5 mL CO kg/day, 5 days/week for 12 months and allowed 9 monthsrecovery.
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uation of forestomachs of EA-treated rats that were
allowed a 19-month recovery (with no exposure to EA)
showed a significant decline in the incidence and sever-
ity ofmucosal cell hyperplasia (5). No treatment-relat-
ed neoplasms were observed in these rats. Considering
the fact that EA is a FS carcinogen in a 2-year gavage
administration study, current investigations have
focused on determining the time required for sustained
hyperplasia induced by EA to lead to neoplastic trans-
formation in the rat FS.
The current studies confirmed earlier findings (5)
that EA-induced hyperplasia in the rat FS is sustained
as long as EA administration continues. These lesions
were selective to the site of EA administration. FS
hyperplasia was sustained for 6 months of EA adminis-
tration and was largely reversible after cessation of
chemical exposure, with no neoplasms occurring when
these animals were sacrificed at 24 months of age.
Hyperplastic lesions in the rat FS were also sustained
for 12 months of EA administration. However when
animals receiving EA for 12 months were sacrificed
after 9 months of recovery, they had developed FS
squamous cell carcinomas (3/13) and papillomas (1/13)
at a combined incidence of 4/13. It is concluded that a
temporal relationship exists between mucosal hyper-
plasia and the development of FS neoplasia. EA-
induced hyperplasia in the skin and respiratory pas-
sages of rats receiving EA by dermal application (3
months) and inhalation (6 months), respectively, has
been reported to reverse after cessation ofexposure to
EA, and no neoplastic lesions were detected (14,15).
This may suggest that a temporal relationship between
EA-induced hyperplasia and carcinogenicity may exist
in other organs directly exposed to EA. The lack of a
carcinogenic response in the two studies may be relat-
ed, at least in part, to the relatively short time ofexpo-
sure to EA and, hence, short period ofsustained hyper-
plasia in the skin and the respiratory tract (14,15).
As observed in the bioassay (6), no significant
increase in hyperplasia or neoplasia was detected in
the present study in any other organ ofthe rats treat-
ed with EA or corn oil vehicle. This further confirms
the tissue specificity in the relationship between EA-
induced hyperplasia and carcinogenesis.
Based on the lack of a carcinogenic response after 3
or 6 months of sustained FS hyperplasia and the fact
that EA is nonmutagenic, we believe that the primary
mechanism of FS neoplasia after exposure to EA is a
consequence of promotion of spontaneously initiated
cells. Initiation may be caused by trace chemical conta-
minants and/or natural carcinogens in the diet by acti-
vation of oncogenes or by DNA replication errors
introduced and fixed in the course of cell replication.
Chemical contaminants of animal feed and naturally
formed carcinogens such as N-nitrosamines were sug-
gested to cause initiation oftumors by the FS carcino-
gen, butylated hydroxyanisole (12).
Finally, we speculated that, whereas a temporal
relationship probably exists between cell proliferation
and tumor development for most chemicals known to
induce proliferation, this relationship may vary signifi-
cantly from one chemical to another and with the tar-
get tissue. Since a mutagenic chemical that also
induces increased cell proliferation should both initiate
and promote its own carcinogenicity, the time of expo-
sure necessary to induce tumor development should be
significantly shorter than that observed for nonmuta-
genic carcinogens.
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